A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
Open Access
- 5 October 2010
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 103 (9), 1415-1421
- https://doi.org/10.1038/sj.bjc.6605935
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 30 references indexed in Scilit:
- Immunogenic death of colon cancer cells treated with oxaliplatinOncogene, 2009
- Combination Chemotherapy and ALVAC-CEA/B7.1 Vaccine in Patients with Metastatic Colorectal CancerClinical Cancer Research, 2008
- Dendritic cell vaccines in melanoma: From promise to proof?Critical Reviews in Oncology/Hematology, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin testsAnnals of Oncology, 2006
- Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancerInternational Journal of Cancer, 2006
- Chemo-Immunotherapy of Metastatic Colorectal Carcinoma With Gemcitabine Plus FOLFOX 4 Followed by Subcutaneous Granulocyte Macrophage Colony-Stimulating Factor and Interleukin-2 Induces Strong Immunologic and Antitumor Activity in Metastatic Colon Cancer PatientsJournal of Clinical Oncology, 2005
- Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapyNature Biotechnology, 2005
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002